KuINins as a New Class of HIV-1 Inhibitors That Block Post-Integration DNA Repair

Area of Science:

• Virology
• Molecular Biology
• Drug Discovery

Background:

• HIV-1 integration into host DNA creates single-strand breaks requiring cellular repair for viral replication.
• Post-integration DNA repair involves the HIV-1 integrase complex interacting with Ku70 protein, facilitating DNA-PK assembly and activation.

Purpose of the Study:

• To develop a novel inhibitor targeting the integrase-Ku70 complex formation.
• To investigate the inhibitor's effect on HIV-1 replication and its mechanism of action.
• To explore the structural basis of the inhibitor's interaction with Ku70.

Main Methods:

• Development of a specific inhibitor (s17) of the integrase-Ku70 complex.
• Assessment of s17's impact on HIV-1 replication in cell culture.
• Molecular dynamics simulations to model s17-Ku70 interaction.
• Synthesis and testing of s17 derivatives to confirm structure-activity relationships.

Main Results:

• The inhibitor s17 effectively blocks HIV-1 replication by targeting post-integration DNA repair.
• s17 specifically inhibits integrase-Ku70 complex formation without disrupting Ku70's role in double-strand break repair (non-homologous end-joining).
• Molecular modeling revealed that two phenyl radicals in s17 interacting with the L76 residue of Ku70 are crucial for its inhibitory activity.

Conclusions:

• s17 represents a promising first-in-class inhibitor of HIV-1 post-integration DNA repair.
• The study highlights the therapeutic potential of targeting the integrase-Ku70 interaction for HIV-1 treatment.
• Future efforts should focus on developing compounds that disrupt integrase binding to Ku70 KuINins.